Cargando…
Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335111/ https://www.ncbi.nlm.nih.gov/pubmed/35320922 http://dx.doi.org/10.3324/haematol.2021.280464 |
| _version_ | 1784759263119278080 |
|---|---|
| author | Quivoron, Cyril Tarabay, Anthony Michot, Jean-Marie Pagès, Arnaud Lecourt, Hélène Aupérin, Anne Danu, Alina Lazarovici, Julien Rossignol, Julien Ghez, David Dartigues, Peggy Vergé, Véronique Massard, Christophe Camara-Clayette, Valérie Ribrag, Vincent Sarkozy, Clémentine |
| author_facet | Quivoron, Cyril Tarabay, Anthony Michot, Jean-Marie Pagès, Arnaud Lecourt, Hélène Aupérin, Anne Danu, Alina Lazarovici, Julien Rossignol, Julien Ghez, David Dartigues, Peggy Vergé, Véronique Massard, Christophe Camara-Clayette, Valérie Ribrag, Vincent Sarkozy, Clémentine |
| author_sort | Quivoron, Cyril |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9335111 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93351112022-08-26 Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma Quivoron, Cyril Tarabay, Anthony Michot, Jean-Marie Pagès, Arnaud Lecourt, Hélène Aupérin, Anne Danu, Alina Lazarovici, Julien Rossignol, Julien Ghez, David Dartigues, Peggy Vergé, Véronique Massard, Christophe Camara-Clayette, Valérie Ribrag, Vincent Sarkozy, Clémentine Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-03-24 /pmc/articles/PMC9335111/ /pubmed/35320922 http://dx.doi.org/10.3324/haematol.2021.280464 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Quivoron, Cyril Tarabay, Anthony Michot, Jean-Marie Pagès, Arnaud Lecourt, Hélène Aupérin, Anne Danu, Alina Lazarovici, Julien Rossignol, Julien Ghez, David Dartigues, Peggy Vergé, Véronique Massard, Christophe Camara-Clayette, Valérie Ribrag, Vincent Sarkozy, Clémentine Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title | Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title_full | Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title_fullStr | Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title_full_unstemmed | Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title_short | Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
| title_sort | cell-free dna sequencing as a potential screening tool for phase i targeted treatment in refractory/relapse diffuse large b-cell lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335111/ https://www.ncbi.nlm.nih.gov/pubmed/35320922 http://dx.doi.org/10.3324/haematol.2021.280464 |
| work_keys_str_mv | AT quivoroncyril cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT tarabayanthony cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT michotjeanmarie cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT pagesarnaud cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT lecourthelene cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT auperinanne cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT danualina cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT lazarovicijulien cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT rossignoljulien cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT ghezdavid cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT dartiguespeggy cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT vergeveronique cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT massardchristophe cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT camaraclayettevalerie cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT ribragvincent cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma AT sarkozyclementine cellfreednasequencingasapotentialscreeningtoolforphaseitargetedtreatmentinrefractoryrelapsediffuselargebcelllymphoma |